Register now

Kick off your virtual DIA experience with a unique opportunity to engage with 20 of the industry’s most influential thought leaders who will give voice to the shifts that are impacting the clinical ecosystem now and their predictions on what the future holds.

This dynamic two-hour virtual panel gives you the opportunity to interact with the expert panel, provide your opinions on the factors that are currently impacting clinical operations, and share your predictions for what’s ahead.

Panelist Bios:

Percival Barretto-Ko, President, Astellas Pharma

Bonnie A Brescia, Founding Principal, Corporate Development Officer, BBK Worldwide

James Corrigan, President & CEO, ERT

Donald A. Deieso, Ph.D., Executive Chairman and Chief Executive Officer, WCG

Ken Getz, Deputy Director, Tufts

Robert Goldman, Ph.D. , Head, Global Clinical Research & Medical Affairs, Sunovion

John Hubbard, Ph.D., CEO, Signant Health

Patrick Lindsay, CEO, UBC

Craig Lipset, Former Head of Clinical Innovation at Pfizer

Michelle Longmire, CEO, Medable

Jamie Macdonald, CEO, Parexel

Alistair Macdonald, CEO, Syneos

Steve Rosenberg, SVP and General Manager Health Science Global Business Unit, Oracle

Julie Ross, President, Advanced Clinical

Christopher J. Schaber, Ph.D., CEO, Solingenix

Craig Serra, Global Head, Strategy and Innovation, Data Operations, Novartis

Rebecca Vermeulen, Vice President Patient and Society Strategy Lead, Product Development, Roche at Genentech

Cynthia Verst, President, R&DS Design & Delivery Innovation, IQVIA

Mark Wildgust, PhD, Vice President, Global Medical Affairs, Oncology, Janssen Pharmaceutical Companies of Johnson & Johnson